Guselkumab in moderate to severe psoriasis in routine clinical care: an Italian 44-week real-life experience
Matteo Megna, Gabriella Fabbrocini, Eleonora Cinelli, Elisa Camela, Angelo Ruggiero
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Risankizumab treatment in psoriasis patients who failed anti-IL17: A 52-week real-life study
Matteo Megna, Luca Potestio, Angelo Ruggiero, Elisa Camela, Gabriella Fabbrocini
DERMATOLOGIC THERAPY (2022)
Tyrosine kinase 2 and Janus kinase-signal transducer and activator of transcription signaling and inhibition in plaque psoriasis
James G. Krueger, Iain B. McInnes, Andrew Blauvelt
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)
Targeted therapies for patients with moderate-to-severe psoriasis: a systematic review and network meta-analysis of PASI response at 1 year
Najeeda Yasmeen, Laura M. Sawyer, Kinga Malottki, Lars-Ake Levin, Eydna Didriksen Apol, Gregor B. Jemec
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Dupilumab in prurigo nodularis: a systematic review of current evidence and analysis of predictive factors to response
Husein Husein-ElAhmed, Martin Steinhoff
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)
L. Borradori, N. Van Beek, C. Feliciani, B. Tedbirt, E. Antiga, R. Bergman, B. C. Boeckle, M. Caproni, F. Caux, N. S. Chandran, G. Cianchini, M. Daneshpazhooh, D. De, D. Didona, G. M. Di Zenzo, M. Dmochowski, K. Drenovska, J. Ehrchen, M. Goebeler, R. Groves, C. Guenther, B. Horvath, M. Hertl, S. Hofmann, D. Ioannides, B. Itzlinger-Monshi, J. Jedlickova, C. Kowalewski, K. Kridin, Y. L. Lim, B. Marinovic, A. Marzano, J. -M. Mascaro, J. M. Meijer, D. Murrell, K. Patsatsi, C. Pincelli, C. Prost, K. Rappersberger, M. Sardy, J. Setterfield, M. Shahid, E. Sprecher, K. Tasanen, S. Uzun, S. Vassileva, K. Vestergaard, A. Vorobyev, I. Vujic, G. Wang, K. Wozniak, S. Yayli, G. Zambruno, D. Zillikens, E. Schmidt, P. Joly
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)
Checklist for Evaluation of Image-Based Artificial Intelligence Reports in Dermatology CLEAR Derm Consensus Guidelines From the International Skin Imaging Collaboration Artificial Intelligence Working Group
Roxana Daneshjou, Catarina Barata, Brigid Betz-Stablein, M. Emre Celebi, Noel Codella, Marc Combalia, Pascale Guitera, David Gutman, Allan Halpern, Brian Helba, Harald Kittler, Kivanc Kose, Konstantinos Liopyris, Josep Malvehy, Han Seung Seog, H. Peter Soyer, Eric R. Tkaczyk, Philipp Tschandl, Veronica Rotemberg
JAMA DERMATOLOGY (2022)
Monkeypox emerges on a global scale: A historical review and dermatologic primer
Josh Bryer, Esther E. Freeman, Misha Rosenbach
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2022)
Real world practice indirect comparison between guselkumab and risankizumab: Results from an Italian retrospective study
Angelo Ruggiero, Gabriella Fabbrocini, Eleonora Cinelli, Matteo Megna
DERMATOLOGIC THERAPY (2022)
Treatment Options and Goals for Patients with Generalized Pustular Psoriasis
James Krueger, Lluis Puig, Diamant Thaci
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2022)
A Systematic Review on Classification, Identification, and Healing Process of Burn Wound Healing
Morteza Abazari, Azadeh Ghaffari, Hamid Rashidzadeh, Safa Momeni Badeleh, Yaser Maleki
INTERNATIONAL JOURNAL OF LOWER EXTREMITY WOUNDS (2022)
Treatment options for leishmaniasis
S. Pradhan, R. A. Schwartz, A. Patil, S. Grabbe, M. Goldust
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2022)
Short-term stress-related increasing cases of alopecia areata during the COVID-19 pandemic
Omer Kutlu, Habibullah Aktas, Isil Gogem Imren, Ahmet Metin
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Early ultrasound for diagnosis and treatment of vascular adverse events with hyaluronic acid fillers
Leonie W. Schelke, Peter Velthuis, Jonathan Kadouch, Arthur Swift
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2023)
Single-Cell RNA-Sequencing Reveals Lineage-Specific Regulatory Changes of Fibroblasts and Vascular Endothelial Cells in Keloids
Xuanyu Liu, Wen Chen, Qingyi Zeng, Baihui Ma, Zhujun Li, Tian Meng, Jie Chen, Nanze Yu, Zhou Zhou, Xiao Long
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)
JAK-inhibitors in dermatology - small molecules, big impact? Overview of the mechanism of action, previous study results and potential adverse effects
Benjamin Klein, Regina Treudler, Jan C. Simon
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2022)
Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of ciclosporin A: a placebo-controlled, randomized, phase III clinical trial (ECZTRA 7)
J. Gutermuth, A. E. Pink, M. Worm, L. Soldbro, C. Bjerregard Oland, S. Weidinger
BRITISH JOURNAL OF DERMATOLOGY (2022)
European guideline (EuroGuiDerm) on atopic eczema - part II: non-systemic treatments and treatment recommendations for special AE patient populations
A. Wollenberg, M. Kinberger, B. Arents, N. Aszodi, G. Avila Valle, S. Barbarot, T. Bieber, H. A. Brough, P. Calzavara Pinton, S. Christen-Zach, M. Deleuran, M. Dittmann, C. Dressler, A. H. Fink-Wagner, N. Fosse, K. Gaspar, L. Gerbens, U. Gieler, G. Girolomoni, S. Gregoriou, C. G. Mortz, A. Nast, U. Nygaard, M. Redding, E. M. Rehbinder, J. Ring, M. Rossi, E. Serra-Baldrich, D. Simon, Z. Z. Szalai, J. C. Szepietowski, A. Torrelo, T. Werfel, C. Flohr
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2022)
Repigmentation in vitiligo using janus kinase (JAK) inhibitors with phototherapy: systematic review and Meta-analysis
Kevin Phan, Steven Phan, Stephen Shumack, Monisha Gupta
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Nemolizumab plus topical agents in patients with atopic dermatitis (AD) and moderate-to-severe pruritus provide improvement in pruritus and signs of AD for up to 68 weeks: results from two phase III, long-term studies
K. Kabashima, T. Matsumura, H. Komazaki, M. Kawashima
BRITISH JOURNAL OF DERMATOLOGY (2022)